Topical Retinoids for Pigmented Skin
Overview
Affiliations
Topical retinoids are an important class of drugs for treating several dermatoses occurring more frequently in patients with pigmented skin, such as melasma, post-inflammatory hyperpigmentation, pseudofolliculits barbae and keloids. They also play a role in managing acne, psoriasis, photoaging, cutaneous T-cell lymphoma, Kaposi sarcoma and disorder of hyperkeratosis in this demographic as well. In general, topical retinoids are well tolerated in pigmented skins. There is little evidence to suggest that patients with darker skin are at increased risk of irritation. However, retinoid dermatitis can induce post-inflammatory hyperpigmentation and attempts should be made to reduce its occurrence by modifying treatment regimens in patients with pigmented skins.
Saki N, Modabber V, Kasraei H, Kasraee B Health Sci Rep. 2024; 7(2):e1930.
PMID: 38410492 PMC: 10895154. DOI: 10.1002/hsr2.1930.
Microneedle-Facilitated Intradermal Proretinal Nanoparticle Delivery.
Limcharoen B, Toprangkobsin P, Kroger M, Darvin M, Sansureerungsikul T, Rujwaree T Nanomaterials (Basel). 2020; 10(2).
PMID: 32093242 PMC: 7075281. DOI: 10.3390/nano10020368.
LE135, a retinoid acid receptor antagonist, produces pain through direct activation of TRP channels.
Yin S, Luo J, Qian A, Yu W, Hu H Br J Pharmacol. 2013; 171(6):1510-20.
PMID: 24308840 PMC: 3954489. DOI: 10.1111/bph.12543.
Retinoids activate the irritant receptor TRPV1 and produce sensory hypersensitivity.
Yin S, Luo J, Qian A, Du J, Yang Q, Zhou S J Clin Invest. 2013; 123(9):3941-51.
PMID: 23925292 PMC: 3754244. DOI: 10.1172/JCI66413.
Cohen J, Makino E, Sonti S, Mehta R J Clin Aesthet Dermatol. 2012; 5(4):33-5.
PMID: 22708006 PMC: 3366447.